Precision Genomics

From Bench to Bedside

Welcome to Genemarkers

Genemarkers provides collaborative services that enhance the utilization of genomics for improving health care, pharmaceutical research and consumer products. We take pride in providing high quality data and customer service. Our strength lies in our flexibility and personalized approach, allowing Genemarkers to meet the unique needs of each of our clients.

Clinical Testing

Pharmacogenomics (PGX) testing is rapidly emerging in clinical practice as medicine moves from a one-size-fits-all model to a precision medicine approach. PGX testing is used to:

  • Reduce trial & error prescribing
  • Minimize adverse drug reactions
  • Improve medication compliance & quality of life
  • Manage health care costs

Clinical Testing - Pharmacogenomics - Clinicians

For Clinicians

Learn More

Clinical Testing - Pharmacogenomics - Patients

For Patients

Learn More

Research Services

Company News

Kalamazoo-based Genemarkers hires CEO as all signs indicate growth

Genemarkers, a Kalamazoo-based biotech company specializing in the application of genomic science to health care, pharmaceutical research, and consumer product development has appointed J. Michael Getz as Chief Executive Officer.  Previously serving as Co-owner and Treasurer of Detroit Oxygen & Medical Equipment Company (Detroit Oxygen), Getz brings over [...]

Genemarkers is proud to begin our collaboration with the state of Ohio to advance proactive, scientific strategies to address the opioid crisis

October 3, 2019 – In an effort to fight the opioid epidemic at its source, Ohio Attorney General Dave Yost today announced the launch of two scientific projects aimed at reducing the number of people who succumb to substance use disorder. “While Ohio’s first responders and treatment and recovery experts are fighting a heroic battle to curb opioid-related fatalities, the key to victory is to stop people from becoming addicted in the first place,” Yost said. “The two projects we are launching aim to prevent people from entering the addiction pipeline.” […]

See full press conference

Reach out to us today to learn more

Contact Us